To save children's lives, china should adopt an initiative to speed introduction of pneumonia vaccines

Health Affairs

Volumn 31, Issue 11, 2012, Pages 2545-2553

  Yu, Hongjie ^a   Yang, Weizhong ^a   Varma, Jay K ^b  

^a Chinese Center for Diseases Control and Prevention   (China)

^b Chinese Centers for Disease Control and Prevention ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; JAPANESE ENCEPHALITIS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE;

ARTICLE; CAUSE OF DEATH; CHINA; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DECISION MAKING; DIAGNOSTIC TEST; DRUG COST; EPIDEMIC MENINGITIS; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH IMPACT ASSESSMENT; HEALTH SURVEY; HEPATITIS A; HUMAN; JAPANESE ENCEPHALITIS; MENINGITIS; MORTALITY; NEWBORN SEPSIS; PERINATAL ASPHYXIA; PNEUMONIA; PREVENTIVE HEALTH SERVICE; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CHINA; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; MASS VACCINATION; NATIONAL HEALTH PROGRAMS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

EID: 84871863104     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.1272     Document Type: Article

References (38)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693): 893-902.
2. Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374(9693): 903-11.
3. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec. 2006;81(47): 445-52.
4. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec. 2007;82(12):93-104.
5. National Bureau of Statistics of China. China statistical yearbook 2010. Beijing: China Statistics Press; 2010. Chinese.
6. Zheng J, Zhou Y, Wang H, Liang X. The role of the China Expert Advisory Committee on Immunization Program. Vaccine. 2010; 28(Suppl 1):A84-7.
7. Rudan I, Chan KY, Zhang JS, Theodoratou E, Feng XL, Salomon JA, et al. Causes of deaths in children younger than 5 years in China in 2008. Lancet. 2010;375(9720): 1083-9.
8. Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type b infections. Cochrane Database Syst Rev. 2007;2:CD001729.
9. GAVI Alliance. Hib Initiative: a GAVI success story [Internet]. Geneva: GAVI Alliance; 2010 [cited 2012 Sep 27]. Available from: http:// www.gavialliance.org/library/news/ roi/2010/hib-initiative-a-gavisuccess-story/
10. Ojo LR, O'Loughlin RE, Cohen AL, Loo JD, Edmond KM, Shetty SS, et al. Global use of Haemophilus influenzae type b conjugate vaccine. Vaccine. 2010;28(43):7117-22.
11. Levine OS, Knoll MD, Jones A, Walker DG, Risko N, Gilani Z. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Curr Opin Infect Dis. 2010;23(3):236-41.
12. Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and x-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;4: CD004977.
13. PneumoACTION. What is Pneumo-ACTION? [Internet]. Baltimore (MD): Johns Hopkins Bloomberg School of Public Health; [cited 2012 Sep 27]. Available from: http:// www.preventpneumo.org/
14. GAVI Alliance. About the pneumococcal AMC [Internet]. Geneva: GAVI Alliance; [cited 2012 Sep 27]. Available from: http://www.gavialliance.org/funding/pneumococcal-amc/about
15. To access the Appendix, click on the Appendix link in the box to the right of the article online
16. Rudan I, Lawn J, Cousens S, Rowe AK, Boschi-Pinto C, Tomasković L, et al. Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet. 2005;365(9476):2031-40.
17. Bhutta ZA. Unraveling the enigma of health statistics in China. Lancet. 2010;375(9720):1058-60.
18. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010; 375(9730):1969-87.
19. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408-16.
20. Guan X, Silk BJ, Li W, Fleischauer AT, Xing X, Jiang X, et al. Pneumonia incidence and mortality in Mainland China: systematic review of Chinese and English literature, 1985-2008. PLoS One. 2010;5(7): e11721.
21. Yang Y, Shen X, Jiang Z, Liu X, Leng Z, Lu D, et al. Study on Haemophilus influenzae type b diseases in China: the past, present, and future. Pediatr Infect Dis J. 1998;17(9 Suppl): S159-65.
22. Yao KH, Yang YH. Streptococcus pneumoniae diseases in Chinese children: past, present, and future. Vaccine. 2008;26(35):4425-33.
23. Shetty S, Cohen AL, Edmond K, Ojo L, Loo J, O'Loughlin R, et al. A systematic review and critical evaluation of invasive Haemophilus influenzae type b disease burden studies in Asia from the last decade: lessons learned for invasive bacterial disease surveillance. Pediatr Infect Dis J. 2010;29(7):653-61.
24. Shen SJ. Serotypes and epidemiological study of pneumococcal infection in 18 provinces (cities) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 1989;10:133-7. Chinese.
25. Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L, et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis. 2008;61(3):256-63.
26. Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50(5):741-4.
27. Liang XF, Wu ZL. Implementation of EPI for 30 years to protect hundreds of millions of people's health. Chinese J Prev Med. 2008;42(Suppl): 4-6. Chinese.
28. Smith JC. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine. 2010; 28(Suppl 1):A68-75.
29. Yip WCM, Hsiao W, Meng W, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet. 2010;375(9720):1120-30.
30. Chinese National Institutes for Food and Drug Control [home page on the Internet]. Beijing: The Institutes; [cited 2012 Sep 27]. Available from: http://www.nicpbp.org.cn/en/CL0309
31. Feng L, Mounts AW, Feng Y, Luo Y, Yang P, Feng Z, et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine. 2010;28(41): 6778-82.
32. National Bureau of Statistics of China. China rural statistical yearbook. Beijing: China Statistics Press; 2010. Chinese.
33. Shearer JC, Stack ML, Richmond MR, Bear AP, Hajjeh RA, Bishai DM. Accelerating policy decisions to adopt Haemophilus influenzae type B vaccine: a global, multivariable analysis. PLoS Med. 2010;7(3): e1000249.
34. Feng Z, Li W, Varma JK. Gaps remain in China's ability to detect emerging infectious diseases despite advances since the onset of SARS and avian flu. Health Aff (Millwood). 2011; 30(1):127-35.
35. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, et al. Blood banking in China. Lancet. 2002; 360(9347):1770-5.
36. Wei GY, Fan MK, Yang YH, Cui Z. Analysis of antibiotics used in Beijing Children's Hospital in the years 1996-2001. China Pharmacy. 2003;14:220-2. Chinese.
37. Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, et al. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine. 2010;28(43): 7123-9.
38. Results for Development Institute. Synthesis report: new vaccine adop tion in lower-middle-income countries [Internet]. Washington (DC): The Institute; c2011 [cited 2012 Sep 27]. Available from: http://www.resultsfordevelopment.org/sites/resultsfordevelopment.org/files/resources/New%20Vaccine%20 Adoption%20in%20LMICs_Final.pdf